Economics Faculty Database
Economics
Arts & Sciences
Duke University

 HOME > Arts & Sciences > Economics > Faculty    Search Help Login pdf version printable version 

Publications of Emma Rasiel    :chronological  alphabetical  combined listing:

%% Papers Published   
@article{fds294368,
   Author = {Califf, RM and Rasiel, EB and Schulman, KA},
   Title = {Considerations of net present value in policy making
             regarding diagnostic and therapeutic technologies.},
   Journal = {American Heart Journal},
   Volume = {156},
   Number = {5},
   Pages = {879-885},
   Year = {2008},
   Month = {Summer},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/19061701},
   Abstract = {BACKGROUND: The pharmaceutical and medical device industries
             function in a business environment in which shareholders
             expect companies to optimize profit within legal and ethical
             standards. A fundamental tool used to optimize decision
             making is the net present value calculation, which estimates
             the current value of cash flows relating to an investment.
             METHODS: We examined 3 prototypical research investment
             decisions that have been the source of public scrutiny to
             illustrate how policy decisions can be better understood
             when their impact on societally desirable investments by
             industry are viewed from the standpoint of their impact on
             net present value. RESULTS: In the case of direct,
             comparative clinical trials, a simple net present value
             calculation provides insight into why companies eschew such
             investments. In the case of pediatric clinical trials, the
             Pediatric Extension Rule changed the net present value
             calculation from unattractive to potentially very attractive
             by allowing patent extensions; thus, the dramatic increase
             in pediatric clinical trials can be explained by the
             financial return on investment. In the case of products for
             small markets, the fixed costs of development make this
             option financially unattractive. CONCLUSIONS: Policy
             decisions can be better understood when their impact on
             societally desirable investments by the pharmaceutical and
             medical device industries are viewed from the standpoint of
             their impact on net present value.},
   Doi = {10.1016/j.ahj.2008.06.038},
   Key = {fds294368}
}

@article{fds294367,
   Author = {Rasiel, EB and Jacob, J},
   Title = {Index Volatility Futures in Asset Allocation: A Hedging
             Framework},
   Journal = {Lazard Asset Management--Investment Research},
   Year = {2008},
   Month = {Spring},
   Key = {fds294367}
}

@article{fds294366,
   Author = {Glickman, SW and Rasiel, EB and Hamilton, CD and Schulman,
             KA},
   Title = {Developing drugs for tuberculosis - Response},
   Journal = {Science (New York, N.Y.)},
   Volume = {315},
   Number = {5815},
   Pages = {1076-1077},
   Publisher = {AMER ASSOC ADVANCEMENT SCIENCE},
   Year = {2007},
   Month = {February},
   ISSN = {0036-8075},
   Key = {fds294366}
}

@article{fds294369,
   Author = {Rasiel, EB and Temple, R},
   Title = {Prime and Subprime Mortgage Foreclosure Analysis},
   Journal = {Lazard Asset Management--Investment Research},
   Year = {2007},
   Key = {fds294369}
}

@article{fds294370,
   Author = {Glickman, SW and Rasiel, EB and Hamilton, CD and Kubataev, A and Schulman, KA},
   Title = {Medicine. A portfolio model of drug development for
             tuberculosis.},
   Journal = {Science},
   Volume = {311},
   Number = {5765},
   Pages = {1246-1247},
   Year = {2006},
   Month = {March},
   ISSN = {0036-8075},
   url = {http://dx.doi.org/10.1126/science.1119299},
   Abstract = {Because of inadequate funding and the lack of promising
             drugs, no new antituberculosis drugs are likely to become
             available before 2010.},
   Doi = {10.1126/science.1119299},
   Key = {fds294370}
}

@article{fds294372,
   Author = {Rasiel, EB and Weinfurt, KP and Schulman, KA},
   Title = {Can prospect theory explain risk-seeking behavior by
             terminally ill patients?},
   Journal = {Medical Decision Making : an International Journal of the
             Society for Medical Decision Making},
   Volume = {25},
   Number = {6},
   Pages = {609-613},
   Year = {2005},
   ISSN = {0272-989X},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/16282211},
   Abstract = {Patients with life-threatening conditions sometimes appear
             to make risky treatment decisions as their condition
             declines, contradicting the risk-averse behavior predicted
             by expected utility theory. Prospect theory accommodates
             such decisions by describing how individuals evaluate
             outcomes relative to a reference point and how they exhibit
             risk-seeking behavior over losses relative to that point.
             The authors show that a patient's reference point for his or
             her health is a key factor in determining which treatment
             option the patient selects, and they examine under what
             circumstances the more risky option is selected. The authors
             argue that patients' reference points may take time to
             adjust following a change in diagnosis, with implications
             for predicting under what circumstances a patient may select
             experimental or conventional therapies or select no
             treatment.},
   Doi = {10.1177/0272989X05282642},
   Key = {fds294372}
}

@article{fds294371,
   Author = {Bollen, NPB and Rasiel, E},
   Title = {The performance of alternative valuation models in the OTC
             currency options market},
   Journal = {Journal of International Money and Finance},
   Volume = {22},
   Number = {1},
   Pages = {33-64},
   Publisher = {Elsevier BV},
   Year = {2003},
   Month = {January},
   url = {http://hdl.handle.net/10161/1967 Duke open
             access},
   Abstract = {We compare option valuation models based on
             regime-switching, GARCH, and jump-diffusion processes to a
             standard "smile" model, in which Black and Scholes (1973)
             implied volatilities are allowed to vary across strike
             prices. The regime-switching, GARCH, and jump-diffusion
             models provide significant improvement over a fixed smile
             model in fitting GBP and JPY option prices both in-sample
             and out-of-sample. The jump-diffusion model achieves the
             tightest fit. A time-varying smile model, however, provides
             hedging performance that is comparable to the other models
             for the GBP options. This result suggests that standard
             option valuation techniques may provide a reasonable basis
             for trading and hedging strategies. © 2003 Elsevier Science
             Ltd. All rights reserved.},
   Doi = {10.1016/S0261-5606(02)00073-6},
   Key = {fds294371}
}


Duke University * Arts & Sciences * Economics * Faculty * Research * Staff * Master's * Ph.D. * Reload * Login